Topic: Papers from the BACR Conference-Response and Resistance in Cancer Therapy

A special issue of Cancer Drug Resistance.

Deadline for manuscript submissions: 20 Dec 2018

Share This Special Issue

Guest Editor(s)

  • Dr. Tim Fenton
    School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK.

    Website | E-mail

  • Prof. Michelle Garrett
    School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK.

    Website | E-mail

  • Prof. Martin Michaelis
    School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK.

    Website | E-mail

  • Dr. Mark Wass
    School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK.

    Website | E-mail

Special Issue Introduction:

This Special Issue will consist of A Selection of Papers from BACR Conference---Response and Resistance in Cancer Therapy (https://www.bacr.org.uk/events/166), held in University of Kent, Canterbury, UK, on 10th–12th September 2018. Despite substantial improvements in recent decades, the prognosis for those cancer patients who suffer from metastatic disease and depend on systemic drug therapy remains poor. Both intrinsic resistance and the formation of acquired drug resistance substantially affects the efficacy of cancer drugs. The advancement of precision medicine approaches holds promise for both the effective guidance of therapies to patients that will respond and the ability to monitor this tumour response. This will require the successful interpretation of ‘omics’ data and a close collaboration between pre-clinical researchers, clinicians, and computational biologists in both academia and industry to develop these strategies. This conference will bring together and showcase cancer researchers from these areas, who will present and discuss the latest advances in understanding the mechanisms of drug resistance in cancer, the identification of biomarkers of drug sensitivity/resistance and how they can be linked to precision medicine approaches. This Special Issue will cover new and novel areas of research pertaining to Cancer Drug Resistance presented at this conference and therefore will represent state-of-the-art and up-to-date coverage of progress.

Keywords:

Cancer drug resistance, prognosis, systemic drug therapy, intrinsic resistance, precision medicine, tumour response, mechanism, bio-marker

Submission Information:

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://cdrjournal.com/pages/view/author_instructions
For Online Submission, please login at http://cdrjournal.com/login
Submission Deadline: 20 Dec 2018
Contacts: Elaine Gao, Managing Editor, editorial@cdrjournal.com

Published Articles
    This special issue is now open for submission.
Cancer Drug Resistance ISSN 2578-532X (Online)
Partners
Copyright © 2018 OAE Publishing Inc. All Rights Reserved.